Integrated Management of Cardiovascular–Renal–Hepatic–Metabolic Syndrome: Expanding Roles of SGLT2is, GLP-1RAs, and GIP/GLP-1-RAs
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(1), P. 135 - 135
Published: Jan. 8, 2025
Cardiovascular-Kidney-Metabolic
syndrome,
introduced
by
the
American
Heart
Association
in
2023,
represents
a
complex
and
interconnected
spectrum
of
diseases
driven
shared
pathophysiological
mechanisms.
However,
this
framework
notably
excludes
liver-an
organ
fundamental
to
metabolic
regulation.
Building
on
concept,
Cardiovascular-Renal-Hepatic-Metabolic
(CRHM)
syndrome
incorporates
liver's
pivotal
role
disease
spectrum,
particularly
through
its
involvement
via
dysfunction-associated
steatotic
liver
(MASLD).
Despite
increasing
prevalence
CRHM
unified
management
strategies
remain
insufficiently
explored.
This
review
addresses
following
critical
question:
How
can
novel
anti-diabetic
agents,
including
sodium-glucose
cotransporter-2
inhibitors
(SGLT2is),
glucagon-like
peptide-1
receptor
agonists
(GLP-1RAs),
dual
gastric
inhibitory
polypeptide
(GIP)/GLP-1RA,
offer
an
integrated
approach
managing
beyond
boundaries
traditional
specialties?
By
synthesizing
evidence
from
landmark
clinical
trials,
we
highlight
paradigm-shifting
potential
these
therapies.
SGLT2is,
such
as
dapagliflozin
empagliflozin,
have
emerged
cornerstone
guideline-directed
treatments
for
heart
failure
(HF)
chronic
kidney
(CKD),
providing
benefits
that
extend
glycemic
control
are
independent
diabetes
status.
GLP-1RAs,
e.g.,
semaglutide,
transformed
obesity
enabling
weight
reductions
exceeding
15%
improving
outcomes
atherosclerotic
cardiovascular
(ASCVD),
diabetic
CKD,
HF,
MASLD.
Additionally,
tirzepatide,
GIP/GLP-1RA,
enables
unprecedented
loss
(>20%),
reduces
risk
over
90%,
improves
HF
with
preserved
ejection
fraction
(HFpEF),
MASLD,
obstructive
sleep
apnea.
moving
organ-specific
approach,
propose
integrates
agents
into
holistic
syndrome.
paradigm
shift
moves
away
fragmented,
organ-centric
toward
more
fostering
collaboration
across
specialties
marking
progress
precision
cardiometabolic
medicine.
Language: Английский
From Cardiovascular-Kidney-Metabolic Syndrome to Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Proposing an Expanded Framework
Biomolecules,
Journal Year:
2025,
Volume and Issue:
15(2), P. 213 - 213
Published: Feb. 2, 2025
Cardiometabolic
diseases
represent
an
escalating
global
health
crisis,
slowing
or
even
reversing
earlier
declines
in
cardiovascular
disease
(CVD)
mortality.
Traditionally,
conditions
such
as
obesity,
type
2
diabetes
mellitus
(T2DM),
atherosclerotic
CVD,
heart
failure
(HF),
chronic
kidney
(CKD),
and
metabolic
dysfunction-associated
steatotic
liver
(MASLD)
were
managed
isolation.
However,
emerging
evidence
reveals
that
these
disorders
share
overlapping
pathophysiological
mechanisms
treatment
strategies.
In
2023,
the
American
Heart
Association
proposed
Cardiovascular-Kidney-Metabolic
(CKM)
syndrome,
recognizing
interconnected
roles
of
heart,
kidneys,
system.
Yet,
this
model
omits
liver—a
critical
organ
impacted
by
dysfunction.
MASLD,
which
can
progress
to
steatohepatitis
(MASH),
is
closely
tied
insulin
resistance
contributing
directly
renal
impairment.
Notably,
MASLD
bidirectionally
associated
with
development
progression
CKM
syndrome.
As
a
result,
we
introduce
expanded
framework—the
Cardiovascular-Renal-Hepatic-Metabolic
(CRHM)
syndrome—to
more
comprehensively
capture
broader
inter-organ
dynamics.
We
provide
guidance
for
integrated
diagnostic
approach
aimed
at
halting
advanced
stages
preventing
further
damage.
addition,
highlight
advances
medical
management
target
shared
pathways,
offering
benefits
across
multiple
systems.
Viewing
whole,
rather
than
discrete
entities,
incorporating
into
framework
fosters
holistic
strategy
offers
promising
path
addressing
cardiometabolic
pandemic.
Language: Английский
Sarcopenia and Cardiogeriatrics: The Links Between Skeletal Muscle Decline and Cardiovascular Aging
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(2), P. 282 - 282
Published: Jan. 14, 2025
Sarcopenia,
an
age-related
decline
in
skeletal
muscle
mass,
strength,
and
function,
is
increasingly
recognized
as
a
significant
condition
the
aging
population,
particularly
among
those
with
cardiovascular
diseases
(CVD).
This
review
provides
comprehensive
synthesis
of
interplay
between
sarcopenia
cardiogeriatrics,
emphasizing
shared
mechanisms
such
chronic
low-grade
inflammation
(inflammaging),
hormonal
dysregulation,
oxidative
stress,
physical
inactivity.
Despite
advancements
diagnostic
frameworks,
EWGSOP2
AWGS
definitions,
variability
criteria
assessment
methods
continues
to
challenge
standardization.
Key
tools
include
dual-energy
X-ray
absorptiometry
(DXA)
bioimpedance
analysis
(BIA)
for
alongside
functional
measures
grip
strength
gait
speed.
The
highlights
bidirectional
relationship
conditions
heart
failure,
aortic
stenosis,
atherosclerotic
disease,
which
exacerbate
each
other
through
complex
pathophysiological
mechanisms.
Emerging
therapeutic
strategies
targeting
mTOR
pathway,
NAD+
metabolism,
senescence-related
processes
offer
promise
mitigating
sarcopenia’s
progression.
Additionally,
integrated
interventions
combining
resistance
training,
nutritional
optimization,
novel
anti-aging
therapies
hold
potential
improving
outcomes.
paper
underscores
critical
gaps
evidence,
including
need
longitudinal
studies
establish
causality
validation
advanced
approaches
clinical
settings.
Future
research
should
leverage
multi-omics
technologies
machine
learning
identify
biomarkers
personalize
interventions.
Addressing
these
challenges
essential
reducing
burden
enhancing
quality
life
elderly
individuals
comorbid
conditions.
aims
guide
future
promote
effective,
individualized
management
strategies.
Language: Английский
The Human Energy Balance: Uncovering the Hidden Variables of Obesity
Diseases,
Journal Year:
2025,
Volume and Issue:
13(2), P. 55 - 55
Published: Feb. 13, 2025
Obesity
has
emerged
as
a
global
epidemic,
creating
an
increased
burden
of
weight-related
diseases
and
straining
healthcare
systems
worldwide.
While
the
fundamental
principle
energy
balance-caloric
intake
versus
expenditure-remains
central
to
weight
regulation,
real-world
outcomes
often
deviate
from
simplistic
predictions
due
multitude
physiological
environmental
factors.
Genetic
predispositions,
variations
in
basal
metabolic
rates,
adaptive
thermogenesis,
physical
activity,
nutrient
losses
via
fecal
urinary
excretion
contribute
interindividual
differences
homeostasis.
Additionally,
factors
such
meal
timing,
macronutrient
composition,
gut
microbiota
dynamics,
diet-induced
thermogenesis
(DIT)
further
modulate
utilization
efficiency.
This
Perspective
explores
key
determinants
balance,
while
also
highlighting
clinical
significance
thrifty
spendthrifty
phenotypes.
Key
strategies
for
individualized
management
include
precision
calorimetry,
circadian-aligned
use
protein-
whole
food
diets
enhance
DIT,
increases
non-exercise
well
mild
cold
exposure
thermogenic
agents
(e.g.,
capsaicin-like
compounds)
stimulate
brown
adipose
tissue
activity.
A
comprehensive,
personalized
approach
obesity
that
moves
beyond
restrictive
caloric
models
is
essential
achieving
sustainable
control
improving
long-term
health.
Integrating
these
multifactorial
insights
into
practice
will
treatment
strategies,
fostering
more
effective
enduring
interventions.
Language: Английский
Skin Microbiota: Mediator of Interactions Between Metabolic Disorders and Cutaneous Health and Disease
Microorganisms,
Journal Year:
2025,
Volume and Issue:
13(1), P. 161 - 161
Published: Jan. 14, 2025
Metabolic
disorders,
including
type
2
diabetes
mellitus
(T2DM),
obesity,
and
metabolic
syndrome,
are
systemic
conditions
that
profoundly
impact
the
skin
microbiota,
a
dynamic
community
of
bacteria,
fungi,
viruses,
mites
essential
for
cutaneous
health.
Dysbiosis
caused
by
dysfunction
contributes
to
barrier
disruption,
immune
dysregulation,
increased
susceptibility
inflammatory
diseases,
psoriasis,
atopic
dermatitis,
acne.
For
instance,
hyperglycemia
in
T2DM
leads
formation
advanced
glycation
end
products
(AGEs),
which
bind
receptor
AGEs
(RAGE)
on
keratinocytes
cells,
promoting
oxidative
stress
inflammation
while
facilitating
Staphylococcus
aureus
colonization
dermatitis.
Similarly,
obesity-induced
dysregulation
sebaceous
lipid
composition
increases
saturated
fatty
acids,
favoring
pathogenic
strains
Cutibacterium
acnes,
produce
metabolites
exacerbate
Advances
metabolomics
microbiome
sequencing
have
unveiled
critical
biomarkers,
such
as
short-chain
acids
microbial
signatures,
predictive
therapeutic
outcomes.
example,
elevated
butyrate
levels
psoriasis
been
associated
with
reduced
Th17-mediated
inflammation,
presence
specific
Lactobacillus
has
shown
potential
modulate
tolerance
Furthermore,
machine
learning
models
increasingly
used
integrate
multi-omics
data,
enabling
personalized
interventions.
Emerging
therapies,
probiotics
postbiotics,
aim
restore
diversity,
phage
therapy
selectively
targets
bacteria
like
without
disrupting
beneficial
flora.
Clinical
trials
demonstrated
significant
reductions
lesions
improved
quality-of-life
metrics
patients
receiving
these
microbiota-targeted
treatments.
This
review
synthesizes
current
evidence
bidirectional
interplay
between
disorders
highlighting
implications
future
directions.
By
addressing
microbiota-mediated
pathways,
precision
strategies
paving
way
patient
outcomes
dermatologic
care.
Language: Английский
Burden of Cardiovascular Hospitalizations and In-Hospital Mortality in Greece: National Trends Over Five Years
Hellenic Journal of Cardiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
Nationwide
epidemiological
studies
provide
crucial
insights
into
the
burden
of
prevalent
and
emerging
diseases,
guiding
development
targeted
health
policies.
This
study
analyzes
trends
in
cardiovascular
disease
(CVD)
hospitalizations
in-hospital
mortality
Greece.
Anonymized
data
were
retrieved
from
Hellenic
Statistical
Authority
to
calculate
hospitalization
rates
(HRs)
per
100,000
population
for
(CV)
sub-causes
2013
2017.
The
statistical
significance
temporal
was
assessed
using
generalized
linear
models
Python.
From
2017,
HRs
myocardial
infarctions
(MIs)
increased
by
9.2%,
heart
failure
(HF)
34.5%,
stroke
12.3%,
cardiac
arrest
62.7%,
pulmonary
embolism
36.6%.
Focusing
on
CVD
leading
cause
(14%)
with
a
HR
1,942.4
population,
HF
being
CV
sub-cause
(12%).
together
stroke,
atrial
fibrillation/flutter
(AF/Af),
coronary
artery
represented
over
60%
all
hospitalizations.
While
more
among
males,
HF,
strokes,
AF/Af
primary
females.
higher
males
majority
sub-causes.
Females
exhibited
across
major
demonstrated
significant
shifts
Greece,
increasing
MIs
HF.
These
findings
highlight
need
optimization
guideline
implementation,
specialized
units
cardiogeriatric
centers
address
challenges
posed
aging
population.
Language: Английский
Metabolic Characteristics of Obese Adolescents with Different Degrees of Weight Loss After Identical Exercise Training Intervention
Xinze Xie,
No information about this author
Gaoyuan Yang,
No information about this author
Yuling Qin
No information about this author
et al.
Metabolites,
Journal Year:
2025,
Volume and Issue:
15(5), P. 313 - 313
Published: May 7, 2025
Objectives:
This
study
aims
to
elucidate
the
metabolic
differences
between
obese
adolescents
categorized
into
low-weight-loss
(LWL)
and
high-weight-loss
(HWL)
groups.
Methods:
The
objective
of
this
is
investigate
characteristics
adolescents,
with
a
focus
on
statistically
significant
individual
observed
in
weight
loss
outcomes
after
same
dietary
exercise
training
intervention.
A
four-week
intervention
was
administered
participants.
Obese
were
LWL
(with
percentage
5–10%)
HWL
>10%)
groups
basis
their
outcomes.
Post-intervention
changes
body
morphology
composition
two
compared
using
Analysis
Covariance
(ANCOVA),
gender
as
covariate.
Additionally,
analyzed
depth;
differential
metabolites
identified
through
ANCOVA
adjusted
for
gender,
followed
by
pathway
analysis.
Results:
After
intervention,
showed
improvements
those
before
(p
<
0.001).
For
example,
decreased
from
80.65
kg
72.35
kg,
BMI
30.57
kg/m2
27.26
kg/m2,
waist
circumference
103.64
cm
94.72
cm,
fat
32.68%
28.54%.
Prior
no
>
0.05).
group
demonstrated
weight,
mass
index,
circumference,
percentage,
mass,
fat-free
water
amount,
skeletal
muscle
controlling
levels
pre-intervention
metabolites,
27
These
fatty
acids,
amino
organic
carnitines,
indoles,
benzoic
carbohydrates.
Notably,
they
significantly
enriched
eight
pathways
involved
acid
metabolism,
biosynthesis,
coenzyme
biosynthesis.
Conclusions:
enhanced
physical
fitness
although
degree
varied
among
individuals.
Considerable
reduction
correlated
lipid,
acid,
carbohydrate,
gut
microbiota
metabolism
enrichment
findings
indicate
that
intrinsic
considerably
influence
responsiveness
exercise-based
weight-loss
interventions.
Language: Английский